Industry News
Pharmaceutical Industry News
Aiming to push Beovu into diabetic macular edema, Novartis hopes longer dosing interval can fix eye drug’s safety woes
Aiming to push Beovu into diabetic macular edema, Novartis hopes longer dosing interval can fix eye drug's safety woes aliu Tue, 08/17/2021 - 07:51
Surprise FDA rejection halts Sesen Bio’s launch in its tracks, putting newly hired sales team in limbo
Surprise FDA rejection halts Sesen Bio's launch in its tracks, putting newly hired sales team in limbo bbulik Mon, 08/16/2021 - 19:39
Buckle up, pharma. Your industry faces a ‘pivotal’ 45 days in D.C., analyst warns
Buckle up, pharma. Your industry faces a 'pivotal' 45 days in D.C., analyst warns kdunleavy Mon, 08/16/2021 - 13:27
Covid Vaccines Produced in Africa Are Being Exported to Europe
Johnson & Johnson is sending shots from South Africa to other parts of the world. African countries are waiting for most of the doses they’ve ordered.
Recro Pharma takes manufacturing business ‘bi-coastal’ with $50M deal for CDMO Irisys
Recro Pharma takes manufacturing business ‘bi-coastal’ with $50M deal for CDMO Irisys fkansteiner Mon, 08/16/2021 - 11:06
Novavax taps Sanofi, Supernus vets amid quest to get its COVID-19 vaccine over the FDA finish line
Novavax taps Sanofi, Supernus vets amid quest to get its COVID-19 vaccine over the FDA finish line fkansteiner Mon, 08/16/2021 - 10:58
FibroGen’s longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a likely overhaul
FibroGen's longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a likely overhaul aliu Mon, 08/16/2021 - 10:56
Pfizer’s tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access
Pfizer's tick-borne encephalitis vaccine TicoVac passes FDA muster, allowing travelers and the military easier access kdunleavy Mon, 08/16/2021 - 09:55
After FibroGen’s FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustat
After FibroGen's FDA rejection in anemia, Akebia CEO aims to seize first-in-class opening with vadadustat aliu Mon, 08/16/2021 - 08:49
Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health quests
Eli Lilly’s Olympic run ends with enduring stories of Team USA athletes’ sport and health quests bbulik Mon, 08/16/2021 - 08:04
The prospect of booster shots is igniting a global health debate.
Citing a lack of scientific evidence, the W.H.O. argues that extra vaccine doses should be sent to poor countries instead.
Living With O.C.D. in a Pandemic
Covid made things worse for many people with obsessive-compulsive disorder. But it also came with a silver lining.
Merck’s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected nhigginsdunn Fri, 08/13/2021 - 15:21
Ogilvy Health’s new PR practice chief talks pharma image and social trends
Ogilvy Health's new PR practice chief talks pharma image and social trends bbulik Fri, 08/13/2021 - 11:43
Organon shares jump as Merck’s new women’s health spinoff posts strong start for biosims, infertility drugs
Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs nhigginsdunn Fri, 08/13/2021 - 11:34
Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon?
Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon? bbulik Fri, 08/13/2021 - 11:32
Jazz’s Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow
Jazz's Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow kdunleavy Fri, 08/13/2021 - 11:15
FDA denies Rigel’s COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data
FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data aliu Fri, 08/13/2021 - 10:01
Fierce Pharma Asia—Seagen’s $2.6B bet on China biotech; Enhertu’s win over Kadcyla; Takeda’s R&D lessons
Fierce Pharma Asia—Seagen's $2.6B bet on China biotech; Enhertu's win over Kadcyla; Takeda's R&D lessons aliu Fri, 08/13/2021 - 06:15
As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments
A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.